To estimate the association between vaginal birth after cesarean delivery (VBAC) rates and primary cesarean delivery rates in California hospitals.
Hospital VBAC rates were calculated using birth certificate and discharge data from 2009, and hospitals were categorized by quartile of VBAC rate. Multivariable logistic regression analysis was performed to estimate the odds of cesarean delivery among low-risk nulliparous women with singleton pregnancies at term in vertex presentation (nulliparous term singleton vertex) by hospital VBAC quartile while controlling for many patient-level and hospital-level confounders.
There were 468,789 term singleton births in California in 2009 at 255 hospitals, 125,471 of which were low-risk nulliparous term singleton vertex. Vaginal birth after cesarean delivery rates varied between hospitals, with a range of 0–44.6%. Rates of cesarean delivery among low-risk nulliparous term singleton vertex women declined significantly with increasing VBAC rate. When adjusted for maternal and hospital characteristics, low-risk nulliparous term singleton vertex women who gave birth in hospitals in the highest VBAC quartile had an odds ratio of 0.55 (95% confidence interval 0.46–0.66) of cesarean delivery compared with women at hospitals with the lowest VBAC rates. Each percentage point increase in a hospital's VBAC rate was associated with a 0.65% decrease in the low-risk nulliparous term singleton vertex cesarean delivery rate.
Hospitals with higher rates of VBAC have lower rates of primary cesarean delivery among low-risk nulliparous women with singleton pregnancies at term in vertex presentation.
Hospitals that have higher rates of vaginal birth after cesarean delivery have lower rates of primary cesarean delivery among low-risk singleton pregnancies at term.
Departments of Obstetrics, Gynecology, and Reproductive Sciences, Epidemiology & Biostatistics, and Medicine, University of California, San Francisco, San Francisco, California; and the Department of Obstetrics and Gynecology, Oregon Health & Science University, Portland, Oregon.
Corresponding author: Melissa G. Rosenstein, MD, MAS, 505 Parnassus Avenue, Box 1483, San Francisco, CA 94143; e-mail: firstname.lastname@example.org.
Dr. Cheng is supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, Grant #HD01262, as a Women's Reproductive Health Research Scholar.
Presented at The 80th Annual Meeting of the Pacific Coast Obstetrical & Gynecological Society, October 2–6, 2013, Walla Walla, Washington.
Financial Disclosure The authors did not report any potential conflicts of interest.